Since the legalization of medical cannabis in the UK in 2018, it has been available for prescription to patients with specific medical conditions. However, navigating the process of obtaining medical cannabis and understanding the associated costs can be challenging. This guide will outline the steps involved in accessing medical cannabis, the differences between private and NHS prescriptions, and what you need to know about reimbursement.
Medical cannabis in the UK can only be prescribed by specialist doctors for conditions where conventional treatments have been ineffective. Common qualifying conditions include severe epilepsy, multiple sclerosis (MS), and chemotherapy-induced nausea and vomiting. It is important to note that medical cannabis is considered a last-resort treatment, and it is only prescribed when standard medications have failed.
Unlike other prescription medications, medical cannabis costs are usually not covered by the NHS, meaning that patients often need to pay out-of-pocket. However, in some cases, private health insurance may cover these costs, depending on the policy.
In the UK, medical cannabis can be prescribed for a limited number of specific conditions when other conventional treatments have not been effective. Access to medical cannabis is highly regulated, and prescriptions are only granted under strict medical supervision by a specialist doctor. Here are the primary conditions for which medical cannabis may be considered:
Severe Epilepsy
Medical cannabis may be prescribed to patients, particularly children, who suffer from rare forms of epilepsy such as Dravet syndrome or Lennox-Gastaut syndrome. These conditions often do not respond well to conventional anti-seizure medications, and medical cannabis has shown potential in reducing seizure frequency.
Multiple Sclerosis (MS)
Cannabis-based medications, such as Sativex, are sometimes prescribed to alleviate muscle stiffness, spasticity, and pain associated with multiple sclerosis. MS patients who have not found relief from traditional therapies may benefit from the muscle relaxant and pain-relieving properties of cannabis.
Chronic Pain
Although prescriptions for chronic pain are limited, medical cannabis may be considered when other pain management strategies, such as opioids or anti-inflammatories, have failed. Conditions like neuropathic pain, which can result from nerve damage, may see some improvement with cannabis-based treatments.
Chemotherapy-Induced Nausea and Vomiting
Cancer patients undergoing chemotherapy may experience severe nausea and vomiting that do not respond to standard anti-nausea medications. Medical cannabis can help reduce these symptoms, improving the patient’s overall quality of life during treatment.
Palliative Care
For patients with advanced or terminal illnesses, medical cannabis may be used to manage pain, improve appetite, and provide overall comfort. It is considered as part of palliative care when conventional pain management options are inadequate.
Tourette's Syndrome
In some cases, cannabis-based medicines may be considered for managing severe tics and symptoms in patients with Tourette’s syndrome, particularly when other medications have been ineffective or have caused intolerable side effects.
Medical cannabis can be obtained in the UK through two main routes: private prescriptions and NHS prescriptions.
Private Prescriptions: This is the simpler but more costly option. A specialist doctor may issue a private prescription if they determine that cannabis is the best option for your condition. Patients can take this prescription to a licensed pharmacy and pay for the medication themselves. This type of prescription is independent of whether the patient has NHS or private insurance and is considered a self-pay prescription.
NHS Prescriptions: NHS prescriptions for medical cannabis are rare and generally only issued when other treatments are unsuitable or have been exhausted. Before issuing an NHS prescription, a request for reimbursement must be submitted to the relevant NHS Trust or health authority, which involves providing detailed medical documentation for assessment on a case-by-case basis.
If you have private health insurance, it is crucial to check with your provider before submitting any cannabis-related claims. Private insurers operate independently of the NHS and have their own policies regarding cannabis reimbursement. Coverage decisions often depend on the specific plan and rate group, so understanding your policy's terms is essential.
NHS patients must go through a more complex process to access medical cannabis. The specialist doctor must submit a detailed request for reimbursement to the NHS before issuing a prescription. This request includes information about your medical history, previous treatments, and justification for using cannabis as a treatment option. Approval is not guaranteed and is based on clinical need and evidence.
To begin the process of obtaining medical cannabis, consult with a specialist doctor who is authorized to prescribe it, such as a neurologist, pain specialist, or oncologist. During your appointment, your doctor will assess your medical history, symptoms, and previous treatments to determine whether medical cannabis is suitable for you. If approved, they will issue a prescription and direct you to a licensed pharmacy that can dispense the medication.
Once you have your prescription, you must take it to a licensed pharmacy that is authorized to dispense medical cannabis. It is important to bring any relevant documents, such as medical records and diagnosis reports, to ensure compliance with dispensing regulations.
In the UK, medical cannabis is not typically covered by the NHS, and reimbursement is rare. If you have private insurance, you can submit a claim for reimbursement along with your prescription and supporting documents. The insurance company will review your case individually and decide whether to cover the costs. In the event of a denial, you may have the option to appeal with additional medical evidence.
NHS funding for medical cannabis is strictly regulated and usually only approved when no other recognized treatment options are available or effective. Decisions are based on clinical need, potential benefits, and a thorough assessment by medical professionals.
The NHS and private insurers will evaluate the following criteria:
If your reimbursement request is denied, you can appeal the decision. Rejections are often due to incomplete exploration of all standard treatments. Consult with your doctor or seek legal advice to strengthen your appeal with additional evidence.
Doctors can issue private prescriptions for cannabis without needing NHS approval; however, patients must cover the costs themselves. NHS coverage requires pre-approval before any prescription can be filled on an NHS-funded basis.
Accessing medical cannabis in the UK involves navigating complex regulations and approval processes. For patients with severe conditions, medical cannabis can be an effective treatment option, but whether the costs are covered depends on clinical assessments and the discretion of insurers or the NHS. Consulting with a specialist doctor and understanding the reimbursement process can help you manage the financial aspects of your treatment and ensure you receive the care you need.
If you believe medical cannabis could benefit your health, speak to your doctor about your options and the best pathway forward.
NHS Guidance on Medical Cannabis
NHS. (n.d.). Medical cannabis (cannabis oil). National Health Service. Retrieved from https://www.nhs.uk/conditions/medical-cannabis/
National Institute for Health and Care Excellence (NICE) Guidelines
National Institute for Health and Care Excellence. (2019). Cannabis-based medicinal products: NICE guideline [NG144]. Retrieved from https://www.nice.org.uk/guidance/ng144
British Medical Journal (BMJ) - Use of Medical Cannabis in the UK
BMJ. (n.d.). Medical cannabis in the UK: An overview of clinical applications and regulations. The British Medical Journal. Retrieved from https://www.bmj.com/
UK Government - Cannabis Scheduling and Licensing
UK Government. (n.d.). Cannabis scheduling and licensing guidance. Retrieved from https://www.gov.uk/government/publications/cannabis-scheduling-and-licensing
Medicines and Healthcare products Regulatory Agency (MHRA)
Medicines and Healthcare products Regulatory Agency. (n.d.). Guidance on cannabis-based products for medicinal use. Retrieved from https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
These references are formatted to provide clear, d
